Onyx Biotec IPO Details: Onyx Biotec Services IPO open date is November 13, 2024 and the IPO will close on November 18, 2024. Onyx Biotec Services IPO is a Book Built Issue. The company to raise around ₹29.34 crores via IPO that comprises fresh issue of ₹29.34 crores and offer for sale up to [.] equity shares with face value of ₹10 each.
Onyx Biotec Services IPO price band is ₹58 to ₹61 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Onyx Biotec Services IPO to list on NSE on November 21, 2024. The allotment of Onyx Biotec Services IPO date is November 19, 2024.
The company reported revenue of ₹53.87 crores in 2024 against ₹39.62 crore in 2023. The company reported Profit of ₹3.03 crores in 2024 against Profit of ₹1.84 crores in 2023. As per the financials the IPO investors should apply the IPO for a long term.
Onyx Biotec IPO Objectives:
- Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use;
- Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections;
- Prepayment or repayment of all or a portion of certain loans availed by the Company; and
- General Corporate Purposes.
Onyx Biotec IPO Review (Apply or Not)
- May Apply
Onyx Biotec IPO Date & Price Band Details:
| IPO Open Date: | November 13, 2024 |
| IPO Close Date: | November 18, 2024 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹58 to ₹61 Per Share |
| Issue Size: | Approx ₹29.34 Crores |
| Fresh Issue: | Approx ₹29.34 Crores |
| Offer for Sale: | Approx [.] Equity Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Onyx Biotec IPO Lot Size:
The minimum market lot for the Onyx Biotec Services IPO is 2,000 shares, with an application amount of ₹122,000.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 2,000 | ₹122,000 |
| Retail Maximum | 1 | 2,000 | ₹122,000 |
| HNI Minimum | 2 | 4,000 | ₹244,000 |
Onyx Biotec IPO Timeline:
The Onyx Biotec Services IPO will open on November 13 and close on November 18. The allotment will be finalized on November 19, with the IPO listing scheduled for November 21.
| IPO Open Date: | November 13, 2024 |
| IPO Close Date: | November 18, 2024 |
| Basis of Allotment: | November 19, 2024 |
| Refunds: | November 20, 2024 |
| Credit to Demat Account: | November 20, 2024 |
| IPO Listing Date: | November 21, 2024 |
Onyx Biotec IPO GMP Today:
The Onyx Biotec SME IPO’s latest GMP stands at ₹10. With a price band of ₹61, the estimated listing price of the IPO is ₹71 (calculated by adding the cap price and today’s GMP). This reflects an expected potential gain of 16.39% per share.
Promoters of Onyx Biotec Services IPO
The promoters of Onyx Biotec Services are Sanjay Jain, Naresh Kumar, and Fateh Pal Singh.
About Onyx Biotec Services IPO
Onyx Biotec Limited commenced operations on May 13, 2015, in the pharmaceutical sector, initially specializing in the supply of sterile water for injection. Over the years, the company has evolved into a leading supplier of sterile pharmaceutical products, offering a wide range of Dry Powder Injections and Dry Syrups for both domestic and international markets. Renowned for delivering high-quality products at affordable prices, Onyx Biotec has established itself as one of India’s top pharmaceutical companies, maintaining a strong reputation for uncompromising quality.
The company operates two manufacturing facilities: Unit I and Unit II. Unit I has the capacity to produce 638,889 units of Sterile Water for Injections per day in a single shift, while Unit II is capable of producing 40,000 units of Dry Powder Injection and 26,667 units of Dry Syrup daily. At Onyx Biotec, a dedicated team works together to create high-quality medicinal products, making them accessible and affordable to ensure that everyone receives the treatment they need.
Onyx Biotec Services IPO Company Financial Report
The company reported revenue of ₹53.87 crores in 2024 against ₹39.62 crore in 2023. The company reported Profit of ₹3.03 crores in 2024 against Profit of ₹1.84 crores in 2023.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹44.98 | ₹41.19 | ₹3.35 | ₹36.84 |
| 2023 | ₹39.62 | ₹37.07 | ₹1.84 | ₹58.72 |
| 2024 | ₹53.87 | ₹49.82 | ₹3.03 | ₹74.14 |
| May 2024 | ₹10.54 | ₹8.79 | ₹1.31 | ₹74.77 |
Onyx Biotec Services IPO Valuation – FY2024
Check Onyx Biotec Services IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 10.58% |
| ROCE: | 12.19% |
| EBITDA Margin: | 15.41% |
| PAT Margin: | 5.64% |
| Debt to equity ratio: | 1.24 |
| Earning Per Share (EPS): | ₹2.54 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 12.19% |
| Net Asset Value (NAV): | ₹18.67 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Suven Pharma | 11.80 | 83.92 | 14.64 | 80.56 | 1,051.35 Cr. |
| JB Chemicals | 35.66 | 53.63 | 18.90 | 188.37 | 3,484.18 Cr. |
Onyx Biotec Services IPO Registrar
Mas Services Limited
Phone: (011) 2610 4142
Email: ipo@masserv.com
Website: https://www.masserv.com/opt.asp
IPO Lead Managers aka Merchant Bankers
- Horizon Management Private Limited
Company Address
Onyx Biotec Limited
Bir Plassi Near Sainimajraropar,
Nalagarh Road
District Solan – 174101,
Phone: +91 172 265 6384
Email: generalinfo@onyxbiotec.com
Website: http://www.onyxbiotec.com/
Onyx Biotec Services IPO FAQs
What is the Onyx Biotec Services IPO?
The Onyx Biotec Services IPO is an SME public offering where the company plans to raise ₹29.34 crores. The price range for the issue is set between ₹58 and ₹61 per share. This IPO will be listed on the NSE.
When will the Onyx Biotec Services IPO be open for subscription?
The IPO is scheduled to open on November 13, 2024, for Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and retail investors. It will close on November 18, 2024.
What is the investor allocation for the Onyx Biotec Services IPO?
The allocation for investors is divided as follows: 50% for QIBs, 15% for NIIs, and 35% for retail investors.
How can you apply for the Onyx Biotec Services IPO?
To apply for the Onyx Biotec Services IPO, you can use the ASBA (Application Supported by Blocked Amount) facility through your bank account. Alternatively, you can apply via UPI through your stockbroker or submit a physical application form through your broker.
What is the issue size of the Onyx Biotec Services IPO?
The total issue size for the Onyx Biotec Services IPO is ₹29.34 crores.
What is the price band for the Onyx Biotec Services IPO?
The price band for this IPO is set between ₹58 and ₹61 per share.
What is the lot size for the Onyx Biotec Services IPO?
The minimum investment is 2000 shares, which requires an amount of ₹122,000.
When is the allotment date for the Onyx Biotec Services IPO?
The allotment of shares is expected to take place on November 19, 2024.
What is the listing date for the Onyx Biotec Services IPO?
The Onyx Biotec Services IPO is expected to be listed on the NSE on November 21, 2024.
